Risks and burdens of postacute outcomes increased in graded manner based on COVID-19 severity
Early Aspirin Cuts In-Hospital Mortality With Moderate COVID-19
Largest benefits seen for patients older than 60 years with no increased risk for hemorrhagic complications
Booster Strategies After Janssen Shot Increased Protection Against Omicron
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses
COVID-19 Vaccination Not Linked to Peripartum Adverse Outcomes
Large population-based cohort of more than 22,000 women shows no increased risks with vaccination during pregnancy
21 States Sue to Overturn CDC Public Transport Mask Mandate
Lawsuit claims mask mandate exceeds the authority of the U.S. Centers for Disease Control and Prevention
No Adverse Outcomes Seen With SARS-CoV-2 Vaccination in Pregnancy
No significantly increased risk reported for preterm birth, stillbirth, SGA, low Apgar score, or neonatal care admission
Memory Deficits Seen in Individuals With ‘Long COVID’
Deficits increased with severity of ongoing self-reported symptoms; severity of initial illness did not influence later cognitive performance
Immune Response to SARS-CoV-2 Infection Persists in Children
Ninety-six percent of those with evidence of nucleocapsid antibodies at baseline still had antibodies more than six months later
FDA Approves Second COVID-19 Booster for Americans 50+
Agency also authorized a second booster for Americans 12 and older who are immune-compromised
2019 to 2020 Saw Risk-Linked Deaths From Heart Disease, Stroke Up
Highest risk-associated increases were seen in non-Hispanic Black people followed by Hispanics, non-Hispanic Asian or Pacific Islanders